Short-term changes in ganglion cell complex in patients with COVID-19 treated with hydroxychloroquine
Citation
Örnek, K., Temel, E., Özcan, G., Kocamış, Ö., & Aşıkgarip, N. (2021). Short-term changes in ganglion cell complex in patients with COVID-19 treated with hydroxychloroquine. Arquivos Brasileiros de Oftalmologia, 84, 408-409.Abstract
Dear Editor,
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly pathogenic human coronavirus that can cause serious life-threatening respiratory disease and multiorgan failure(1). Despite the swift global spread of coronavirus disease 19 (COVID-19), no reliable clinical data are available to endorse any specific medical therapy. Organ-supportive therapy, including respiratory therapy, in acute pulmonary failure is recommended by physicians worldwide...